Gina Mazzariello
Chief Legal Officer · Amylyx Pharmaceuticals, Inc.
- 2024
- Sep 14, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gina Mazzariello files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Joshua B. Cohen - $3.60M in AMLX purchases and sales in the last 12 months
- Justin B. Klee - $3.59M in AMLX purchases and sales in the last 12 months
- George M. Milne Jr. - $831K in AMLX purchases and sales in the last 12 months
- James M. Frates - $554K in AMLX purchases and sales in the last 12 months
- Camille L. Bedrosian - $513K in AMLX purchases and sales in the last 12 months
- Karen Firestone - $152K in AMLX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gina Mazzariello?
Gina Mazzariello is a corporate insider, tracked as Chief Legal Officer of Amylyx Pharmaceuticals, Inc. (AMLX). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Gina Mazzariello submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Gina Mazzariello been buying or selling stock?
Recorded transactions: 0 open-market purchases and 11 open-market sales ($1.45M) across all tracked filings.
